Good evening :)
$
₹
Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

TNDM

NASDAQ
Asset Logo

Tandem Diabetes Care Inc

TNDM

NASDAQ
$17.816.47% (-1.23)
$
₹
$17.816.47% (-1.23)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Small Cap

With a market cap of $1.2B the stock is ranked 2515

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

9.95
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.91
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-6.08%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 25 analysts reports

Buy
13 analysts
Hold
12 analysts
Sell
0 analyst

Price Upside

+45.73%

Earnings Growth

+54.84%

Rev. Growth

+5.69%

See Detailed Forecast

Company Profile

Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
40.97
40.97
1Y Return
13.03%
13.03%
Buy Reco %
82.14
82.14
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
38.09
38.09
1Y Return
7.61%
7.61%
Buy Reco %
83.33
83.33
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
53.29
53.29
1Y Return
10.52%
10.52%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
24.41
24.41
1Y Return
16.08%
16.08%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
32.68
32.68
1Y Return
6.33%
6.33%
Buy Reco %
76.66
76.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 45.73% growth, versus a trailing 3-year CAGR of 7.56%.

2026
Current$19.05Baseline
Analyst Target - 1 year
Target$27.76+45.73%

All values in $

202220232024202520262027$25.22$33.30$41.37Target+45.73%
2026
Current$19.05Baseline
Analyst Target - 1 year
Target$27.76+45.73%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 5.69% growth, versus a trailing 3-year CAGR of 8.19%.

2025
Current$1.01Baseline
Forecast for Dec 2026
High$1.08+6.59%
Average$1.07+5.69%
Low$1.06+4.83%

All values in $ Billion

2021202220232024202520260.700.800.740.941.01Low+4.83%Average+5.69%High+6.59%
2025
Current$1.01Baseline
Forecast for Dec 2026
High$1.08+6.59%
Average$1.07+5.69%
Low$1.06+4.83%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

2025
Current$-1.47Baseline
Forecast for Dec 2026
High$-0.45+69.11%
Average$-0.66+54.84%
Low$-0.91+38.1%

All values in $

2021202220232024202520260.23-0.98-1.58-1.92-1.47Low+38.1%Average+54.84%High+69.11%
2025
Current$-1.47Baseline
Forecast for Dec 2026
High$-0.45+69.11%
Average$-0.66+54.84%
Low$-0.91+38.1%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

249.2
-21.1
290.3
-0.5
247.2
-20.3
254.5
-21.1
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue191.67221.91363.28282.64234.42240.67249.25290.38247.22254.56
Net Income-42.71-30.81-23.250.75-130.55-52.4-21.16-0.58-20.39-21.16
Net Profit Margin-22.28%-13.88%-6.40%0.26%-55.69%-21.77%-8.49%-0.20%-8.24%-8.31%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Tandem Diabetes Care Inc -9.950
Abbott Laboratories40.973.721.57
Danaher Corporation38.092.981.29
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare TNDM with any stock or ETF
Compare TNDM with any stock or ETF
Comparing from
TNDM
ABT
DHR
Loading...

Frequently asked questions

  1. Tandem Diabetes Care Inc (TNDM) share price today is $17.81 as of November 5, 2026 at 11:25 PM IST. The stock touched a day high of $19.52 and a day low of $17.81.

  2. Tandem Diabetes Care Inc stock trades on NASDAQ under the ticker symbol TNDM.

  3. Tandem Diabetes Care Inc's market capitalization is $1.22B as of November 5, 2026 at 11:25 PM IST.

  4. Tandem Diabetes Care Inc's price-to-earnings (P/E) ratio is N/A as of November 5, 2026.

  5. Tandem Diabetes Care Inc's price-to-book (P/B) ratio is 9.95 as of November 5, 2026.

  6. Yes, You can buy Tandem Diabetes Care Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Tandem Diabetes Care Inc shares in three steps: 1. Search Tandem Diabetes Care Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Tandem Diabetes Care Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Tandem Diabetes Care Inc (TNDM) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.5612 shares at the current price of $17.81.

Loading...